Forum Views ()
Forum Replies ()
Read more with google mobile :
Drug firms go online to test and sell medicines
|
Edition:
U.S.
Article
Comments (0)
Follow Reuters
Facebook
Twitter
RSS
YouTube
Read
China warns U.S. debt-default idea is "playing with fire"
9:16am EDT
Americans rated most hilarious in global poll
07 Jun 2011
Obama administration to appeal healthcare ruling
7:18am EDT
U.S. cancer drugs shortage has doctors scrambling
07 Jun 2011
Germany defends E.coli response as death toll rises
9:40am EDT
Discussed
73
”The world is getting warmer”: Romney
69
Moody’s sounds alarm over U.S. debt limit and deficits
56
Diamond says time to withdraw as Fed nominee
Watched
Bodypainters apply their skill
Mon, Jul 19 2010
Bernanke sparks fifth-day fall
3:02am EDT
Four-year-old takes art world by storm
Mon, Jun 6 2011
Drug firms go online to test and sell medicines
Tweet
Share this
Email
Print
Related News
UPDATE 4-Merck ends trial of Intercell's MRSA vaccine
8:14am EDT
Exelixis shares fall on cancer drug safety concerns
Mon, Jun 6 2011
Next up for melanoma treatment: drug cocktails
Mon, Jun 6 2011
Special report: If Monterrey falls, Mexico falls
Wed, Jun 1 2011
Special Report: An end to AIDS?
Wed, Jun 1 2011
Analysis & Opinion
5 reasons to join a startup after graduating
Quick hits on money and politics
Related Topics
Health »
Technology »
Media »
People work on laptop computers in this file photo.
Credit: Reuters/Susana Vera
By Ben Hirschler
LONDON |
Wed Jun 8, 2011 7:47am EDT
LONDON (Reuters) - Prompted by the soaring cost of developing and marketing their medicines, drug companies are embracing the Internet in a bid to drive down costs.
The hope is that digital tools will not only make them more efficient, but also smarter and nimbler.
Pfizer, the world's biggest drugmaker, is pushing the envelope on clinical trials by conducting the first ever "virtual" study of a medicine, in which patients will be able to participate by using home computers and smartphones.
At the same time, several large companies are changing the way they communicate and market their medicines to doctors by establishing new online services to answer product queries and let physicians order free samples.
The moves come as the cost of drug research continues to spiral upwards and companies face a wave of patent expiries on some of their biggest selling products, leading to an unprecedented round of cost-cutting across the industry, with big job cuts in both marketing and research.
"Drug companies are going to look at any method of cutting costs and the whole marketing process is certainly changing," said Dominic Valder, industry analyst at Evolution Securities.
Pfizer's online study of its overactive-bladder drug Detrol, announced this week, has the blessing of the U.S. Food and Drug Administration (FDA) and will be closely watched as a test case by other companies.
In itself, the 600-patient pilot study is not likely to throw up any major surprises, since it aims to replicate the results of a previously completed traditional trial to assess the validity of the new approach.
But Steve Cummings, an emeritus professor of medicine at the University of California, San Francisco, believes it could be the start of something much bigger.
"This virtual method enables scientists to conduct trials more efficiently. Additionally, as more people participate in trials conveniently from home, the results of trials may apply to a broader patient population," he said.
Cummings has a vested interest, since he is chief executive of the company Mytrus, which designed the study for Pfizer. Mytrus's business model is built on the idea that people can safely participate in clinical trials from home, thereby improving recruitment and compliance, as well as cutting costs.
The U.S. patients in Pfizer's 16-week trial will receive blinded medications by mail -- either Detrol or placebo -- and will record their symptoms and report back to researchers over the Internet. They will get paid up to $175 for taking part, according to the trial's website (j.mp/ltRO0F).
Valder said such online methods were most likely to be used in post-launch tests of established drugs, like Detrol, rather than in make-or-break studies needed to get a new drug approved. But in future it might be possible to combine data collected online with information from traditional face-to-face tests.
ONLINE MARKETING TOOLS
Using online tools to market medicines is less revolutionary but the approach has gained considerable momentum in the past two years, according to analysts and industry executives.
AstraZeneca, for example, has set up a website for U.S. doctors called AZ TouchPoints that provides online sample ordering, formulary information and patient education materials.
The group's heightened focus on online communication with prescribers coincides with a recent decision to end payments for physicians to attend international meetings.
Other drugmakers have yet to follow AstraZeneca in scrapping such trips but an increasing number are relying on the Internet, rather than in-person meetings, to get their message across. Sanofi's iPractice site, for example, also allows U.S. doctors to request samples and product information online.
Such digital marketing techniques are starting to replace some of the traditional activities of pharmaceutical sales reps, who nowadays are paid more to be trusted collaborators with healthcare providers rather than simply salesmen.
The new frontier in marketing is social media -- and drugmakers, like many companies, are dipping into Facebook and Twitter. Where this avenue will lead is still unclear, as the industry is still awaiting social media policy guidelines from the FDA that were originally promised by the end of 2010.
(Editing by Mike Nesbit)
Health
Technology
Media
Related Quotes and News
Company
Price
Related News
Tweet this
Link this
Share this
Digg this
Email
Reprints
We welcome comments that advance the story directly or with relevant tangential information. We try to block comments that use offensive language, all capital letters or appear to be spam, and we review comments frequently to ensure they meet our standards. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of Reuters.
Comments (0)
Be the first to comment on reuters.com.
Add yours using the box above.
Social Stream (What's this?)
© Copyright 2011 Thomson Reuters
Editorial Editions:
Africa
Arabic
Argentina
Brazil
Canada
China
France
Germany
India
Italy
Japan
Latin America
Mexico
Russia
Spain
United Kingdom
United States
Reuters
Contact Us
Advertise With Us
Help
Journalism Handbook
Archive
Site Index
Video Index
Reader Feedback
Mobile
Newsletters
RSS
Podcasts
Widgets
Your View
Analyst Research
Thomson Reuters
Copyright
Disclaimer
Privacy
Professional Products
Professional Products Support
Financial Products
About Thomson Reuters
Careers
Online Products
Acquisitions Monthly
Buyouts
Venture Capital Journal
International Financing Review
Project Finance International
PEhub.com
PE Week
FindLaw
Super Lawyers Attorney Rating Service
Reuters on Facebook
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Other News on Wednesday, 8 June 2011 Beyonce's new album "4" leaks online
U.S. and Pakistan authorities dispute militant's death
|
French government bans journalists from saying "Facebook" and "Twitter" on-air
Canucks defenseman Aaron Rome banned four games for blindside hit
Ill-gotten wealth frozen of clan members linked to massacre
Jewish settlers accused in West Bank mosque attack
|
IEA expects natural gas use to soar by 50 percent in coming years
Sergio Garcia biggest name among U.S. Open qualifiers
Libya says NATO attacks on Tripoli kill 31
|
Oklahoma Rep. Boren won't seek fifth term
NATO-Russia drill aims to prevent September 11 attack
|
Soaring Health Costs Pinned On Medical Devices
Residents flee Sudan flashpoint state clashes
|
German solar demands fuel industry growth
Global support for U.S. killing of bin Laden: poll
|
Eurozone sees overall increase in retail sales for May
Rains, mudslides kill 10 in cholera-stricken Haiti
|
Nintendo lifts lid on Wii U, eyes hardcore gamers
|
New Jersey court denies blogger shield protection
|
Analysis: Retailers see tablets hitting classrooms soon
|
iRobot sets path to Latin America, China: CEO
|
Toronto waterfront set for ultra-broadband
|
Michael Jackson concert insurers decline to pay out
|
Scottish Power hikes energy bill by almost $250 a year
Yemen's Saleh injuries believed more serious
|
Japan admits of nuclear melt-through in U.N. report
"Captain America" star Chris Evans reveals he's going bald
Gaddafi defiant as NATO intensifies Tripoli strikes
|
Russia, Norway resolve oil-rich Barents Sea dispute
Bernanke forecasts U.S. growth despite recent indicators of economic weakness
Khloe Kardashian has wardrobe malfunction during live morning show
Berwick: "I've Got The Back" Of Medicare Beneficiaries
Floyd Mayweather Jr. to return to ring on September 17 vs. Victor Ortiz
Carstens seeks support of developing nations to remove European hold on top IMF post
Extreme Couponing Renewed for Second Seasons
Syrians flee town as troops approach
|
Humala seeks to reassure Peru mining companies on tax
|
U.S. aid to Afghanistan needs sharper focus: study
|
New E.coli cases dropping significantly in Germany
|
N.Korea test fired short-range missile last week: Yonhap
|
Resignation of Brazil's Palocci leaves a void
|
China floods kill 24, force 100,000 to evacuate
|
Web companies test Internet's readiness for future
|
Facebook facial recognition technology sparks renewed concerns
|
Sony sees brisk sales of new handheld games device
|
Nintendo Wii U underwhelms investors
|
Vidyo rolls out low-cost video-conferencing
|
RSA offers to replace SecurIDs after Lockheed hacking
|
Michael Jackson concert insurers decline to pay out
|
Mystery surrounds Super 8 in a summer of sequels
|
Aerosmith returning to studio for long-delayed album
|
Judy Moody children's books find new life on film
|
Matteo Manassero will be crowd favorite at BMW Italian Open
Arizona State completes dominant softball season with national title
Scotty McCreery's second single "Out of Summertime" leaks online
Production at Intel plant normal after fire
HIV's top five recent successes
Rohingyas in Malaysia seek education, opportunities
Vanessa Marcil Giovinazzo leaving 'General Hospital'
Nicholas Cage's son admitted to hospital for mental evaluation
Qaeda's Zawahri says U.S. facing Muslim rebellion
|
'Real Housewives of New Jersey' renewed for fourth season
IMF expects Japan's economy to shrink this year
Germany defends E.coli response as death toll rises
|
Anticipation in Tripoli as net tightens on Gaddafi
|
China floods kill 52, force 100,000 to evacuate
|
Defiant Iran plans big rise in nuclear enrichment
|
Greece warns dissenters against rejecting austerity
|
Pakistan militant group vows to escalate fight in Afghanistan
|
Web companies test Internet's readiness for future
|
Apple, Google cloud can help curb online piracy: U.S.
|
FBI director says to boost focus on cyber threats
|
Senators seek crackdown on Bitcoin currency
|
Zynga said to favor small IPO float: report
|
Gartner cuts 2011 PC forecast, as tablets surge
|
Drug firms go online to test and sell medicines
|
Apple, Google cloud can help curb online piracy: U.S.
|
A Minute With: Horror king John Carpenter on The Ward
|
Oxford academic finds tantalizing clue to Ophelia
|
Greece at new risk of being pushed off euro
Bodies of missing Tenn. mom, Jo Ann Bain, and daughter found
Female Breasts Are Bigger Than Ever
AMD Trinity Accelerated Processing Units Now in Volume Production
The Avengers (2012 film), made the second biggest opening- and single-day gross of all-time
AMD to Start Production of piledriver
Ivy Bridge Quad-Core, Four-Thread Desktop CPUs
Islamists Protest Lady Gaga's Concert in Indonesia
Japan Successfully Broadcasts an 8K Signal Over the Air
ECB boosts loans to 1 trillion Euro to stop credit crunch
Egypt : Mohammed Morsi won with 52 percent
What do you call 100,000 Frenchmen with their hands up
AMD Launches AMD Embedded R-Series APU Platform
Fed Should not Ignore Emerging Market Crisis
Fed casts shadow over India, emerging markets
Why are Chinese tourists so rude? A few insights